Запальні захворювання органів малого таза: сучасні уявлення про етіологію, принципи діагностики та лікування
DOI:
https://doi.org/10.15574/HW.2020.148.7Ключові слова:
запальні захворювання органів малого таза, сальпінгіт, ендометрит, мікробіоценоз, статева екзоінфекція, діагностика, принципи лікуванняАнотація
Запальні захворювання органів малого таза (ЗЗОМТ) посідають перше місце у структурі гінекологічної захворюваності і є однією з причин порушення функції не тільки репродуктивних органів, але і різних систем жіночого організму, безплідності, зниження якості життя. До ЗЗОМТ належать запальні процеси тіла матки, маткових труб, яєчників і тазової очеревини.
У статті наведені сучасні погляди щодо етіологічних чинників, етапів розвитку ендогенної інфекції і її клінічних проявів. Розглянуто механізми ендокринної та імунної регуляції мікробіоценозу піхви, а також взаємини ендогенної мікрофлори і збудників екзогенних статевих інфекцій. Представлені діагностичні підходи та принципи терапії ЗЗОМТ з урахуванням вираженості інфекційного процесу.
Посилання
Ankirskaya AS, Muravyova VV. 2000. The species composition and some biological properties of lactobacilli in various conditions of the vaginal microecology. Obstetrician. and gynecol. 3:26–28.
Benyuk VA, Lastovetskaya LD, Usevich IA, Shcherba EA, Samsonova SS. 2008. Modern approaches to the diagnosis and treatment of inflammatory diseases of the uterus. Women's Health 2(34):67-70.
Bukharin OV, Valyshev AV, Gilmutdinova FG et al. 2006. Ecology of human microorganisms. Ekaterinburg: Ural Branch of the Russian Academy of Sciences.
Krasnopolsky VI et al. 2004. The effect of infections on the reproductive system of women. Ros. Vestn. obstetrician.- gynecol. 4;5:26-30.
Serov VN et al. 2008. Gynecology: A guide for doctors. Ed. Serova VN, Kira EF. M, Litterra:840.
Gritsenko VA, Ivanov YuB. 2009. Role of persistent properties of microorganisms in the pathogenesis of endogenous bacterial infections. Vestn. Ural. honey. Acad. science. 2:35–39.
Duda VI. 2008. Gynecology. 2nd ed. erased. Minsk, Harvest: 896, 199-202.
Ed. Vorobyev AA et al. 2006. Immunology and allergology (color atlas): Textbook. The allowance.M,Practical. honey. Gynecology: National Hand. / Ed. Kulakova VI, Manukhin IB, Savelyeva GM. M, GEOTARMEDIA. 2007.
Ed. Prilepskaya VN. Sexually transmitted infections: Clinical lectures. M, GEOTAR-Media. 2014.
Katkova IP. 2002. Reproductive health of Russians. Population. 4:39–42.
Ed. Serova VN, Sukhikh GT. Clinical recommendations. Obstetrics and gynecology (4th ed.). M, GEOTAR-Media. 2014.
Kozlova VI, Puchner AF. 1997. Viral, chlamydial and mycoplasma diseases of the genitals. M, Filin:536.
Kornatska AG, Vovk IB, Chubei GV. 2012. Zapalnnye seizure of the pelvic organs, due to infections, which are transmitted by the style of the hat. Health’s Ukraine 4:38-39.
Korshunov NM, Volodin NN, Efimov BA et al. 1999. Microecology of the vagina. Correction of microflora in vaginal dysbiosis: Textbook. allowance. M, VUNMTS Ministry of Health of the Russian Federation.
Kosey NV. 2013. Modern principles for the treatment of inflammatory diseases of the female genital organs. Reproductive Endocrinology 1(9):78-85. https://doi.org/10.18370/2309-4117.2013.9.78-85
Kocherovets VI, Bunyatyan ND. 2011. Normal microflora of the female genitourinary tract and preparations for its correction: Textbook. allowance. M, ACTEON.
Kulakov VI, Prilepskaya VN, Radzinsky VE. 2006. A guide to outpatient care in obstetrics and gynecology. M, GEOTAR-Media.
Lebedeva OP, Kalutsky PV, Pakhomov SP et al. 2009. Congenital immunity of the female genital tract and its hormonal regulation (mini-review). Scientific. Vedomosti Belgorod. state University (Medicine, pharmacy) 12(67):25–31.
Medvedev BI, Dolgushina VF. 1993. Local anti-infectious immunity of the female reproductive system. Obstetrician. and gynecol. 4:7–9.
Medvedev BI, Kazachkova EA, Cossacks EL. 2000. Features of local immunity in women with chronic inflammatory diseases of the pelvic organs associated with chlamydia. Journal. microbiol., epidemiol. and immunobiol. 2:89–92.
Mirsky VYe, Rischuk SV. 2012. Diseases of the reproductive system in children and adolescents (andrological aspects): Hands. for doctors. SPb, SpetsLit.
Mikhalevich SI. 2002. Overcoming infertility: diagnosis, clinic. treatment: textbook. allowance for students of the specialty «Medical and preventive care» honey. universities. Minsk: Belaruskaya Navuka: 191, 32.
Naumov IA, Tishchenko EM. 2012. Inflammatory diseases of the female genital organs: the organization of medical care for patients in 1944-1994 (on the example of the Grodno region): monograph. Grodno, State State Medical University 248.
Prilepskaya VN. 2002. Infections in gynecology. Features of infectious processes of the lower genital tract. Possibilities of drug therapy for local use. Gynecol. 2;2:17–19.
Prozorovsky SV, Rakovskaya IV, Vulfovich YuV. 1995. Medical mycoplasmology. M, Medicine:288. Balabanov DN. 2009. Antigenemia in urogenital mycoplasma infections: Abstract. dis. Cand. honey. sciences. M.
Rischuk SV, Dushenkova TA. 2013. Optimization of the diagnosis of reproductive significant infections in couples. Terra Medica. 4:20–33.
Rischuk SV. 2013. Sexual infections as the main cause of the deterioration in the reproductive health of couples. Terra Medica. 3:5–11.
Rischuk SV. 2015. Infectious and inflammatory diseases of the female genital organs: etiology, fundamental approaches to diagnosis and treatment. TERRA MEDICA. 4:4-15:4.
Rischuk SV, Malisheva AA. 2014. Endogenous vaginal microbiota and its violation. Diagnosis and principles of correction. TERRA MEDICA. 2:9-21.
Guide to Gynecology. Ed. RAMS prof. E.K. Haylamazyan. M, MEDpress-inform. 2012.
Sepsis at the beginning of the 21st century. Classification, clinical diagnostic concept and treatment. Pathological and anatomical diagnosis: Practical. hands. Ed. Saveliev VS, Gelfand BR. 2006. M, Litterra.
Tatarchuk TF, Kosey NV. 2012. Empirical therapy of vaginal infections. - Institute of Pediatrics, Obstetrics and Gynecology of Ukraine.
Utkin EV, Kulavsky VA. Modern features of the clinical course of inflammatory diseases of the uterine appendages. Actual issues of obstetrics and gynecology: Sat. scientific tr interregional scientific - prakt. Conf., Krasnoyarsk, March 20-21, 2008. Ministry of Health and Social Development of the Russian Federation. Feder., Ministry of Health and Social Development of the Krasnoyarsk Territory, Ros. assoc. obstetrician-gynecol., Krasnoyarsk. Gos. honey. un-t them. prof. V.F. War-Yasenetsky, Rec .: Serov VN et al. 2008. Krasnoyarsk: Krasnoyarsk State Medical University: 146–149.
Tselkovich LS, Rogacheva VS. 1998. Reproductive function in women living under the influence of adverse environmental factors. Obstetrician. and gynecol. 2:24–27.
Shenderov BA. 1998. Medical microbial ecology and functional nutrition. T. I. Microflora of humans and animals and its functions. M, Grant.
Shcherba OA, Lastovetska LD, Polovinka VO, Shako VA. 2019. Clinical aspects of asocial candidiasis - herpetic vulvovaginitis. Women's Health 7(143):85-89.
Yaglov VV. 2001. Inflammatory diseases of the pelvic organs. Gynecol. 1;3:40–43.
Hillier SL et al. 1988. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N. Engl. J. Med. 319:972–978. https://doi.org/10.1056/NEJM198810133191503; PMid:3262199
Agarwal AK, Wilmer WA, Bay WH. 2002. Pneumococcal and gonococcal peritonitis due to vaginitis. Perit. Dial. Int. 22;6:731–732. https://doi.org/10.1177/089686080202200618
Arntzen КJ, Kjollesdal AM, Halgunset J. 1998. TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J. Perinat. Med. 26:17–26. https://doi.org/10.1515/jpme.1998.26.1.17; PMid:9595363
Deguchi T et al. 2004. Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis. Sex. Transm. Dis. 31:192–195. https://doi.org/10.1097/01.OLQ.0000114653.26951.71; PMid:15076934
Berman JM, Harrison BV. 1987. Low birth weights, prematurity and endometritis association with prenatal infection. JAMA. 257;4:1189–1194. https://doi.org/10.1001/jama.257.9.1189; PMid:3806917
Bevan CD, Ridgway GL, Rothermel CD. 2003. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J Int Med Res 31:45–54. https://doi.org/10.1177/147323000303100108; PMid:12635534
Boothby M, Page J, Pryor R et al. 2010. A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease. Int J STD AIDS 21:195–7. https://doi.org/10.1258/ijsa.2009.009374; PMid:20215625
Boris S, Barbes C. 2000. Role played by lactobacilli in controlling the population of vaginal pathogens. Micr. Infect. 2;5:543–546. https://doi.org/10.1016/S1286-4579(00)00313-0
Burnett AM, Anderson CP, Zwank MD. 2012. Laboratory-confirmed gonorrhea and/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis. Am J Emerg Med 30:1114–7. https://doi.org/10.1016/j.ajem.2011.07.014; PMid:22030186
Gibbs RS. 1995. A revive of premature birth and subclinical infection. Clin. Perinatal. 22;2: 281–342. Jennings RT, Baker ES. 2000. Gynecological and reproductive issues for women in space: a review. Obstet. Gynecol. Surv. 55;2: 109–116. https://doi.org/10.1097/00006254-200002000-00025; PMid:10674254
Golden MR, Whittington WL, Handsfield HH et al. 2005. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 352:676–85. https://doi.org/10.1056/NEJMoa041681; PMid:15716561
Gray Y, Libbey NP. 2001. Xanthogranulomatous salpingitis and oophoritis: a case report and review of the literature. Arch. Pathol. Lab. Med. 125;2:260–263.
Grenabo L, Hedelin H, Pettersson S. 1988. Urinary infection stones caused by Ureaplasma urealyticum: a review. Scand. J. Infect. Dis. Suppl. 53:46–49.
Grimes DA. 2000. Intrauterine device and upper-genital-tract infection. Lancet 356:1013–9. https://doi.org/10.1016/S0140-6736(00)02699-4
Haefner HK. 1999. Current evaluation and management of vulvovaginitis. Clin. Obstet. Gynecol. 42;2:184–195. Sobel JD. 1997. Vaginitis. N. Engl. J. Med. 337: 1896–1903. https://doi.org/10.1097/00003081-199906000-00004; PMid:10370840
Heystek M, Ross JD. 2009. A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. Int J STD AIDS 20:690–5. https://doi.org/10.1258/ijsa.2008.008495; PMid:19815913
Hosenfeld CB, Workowski KA, Berman S et al. 2009. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 36:478–89. https://doi.org/10.1097/OLQ.0b013e3181a2a933; PMid:19617871
Jares EJ, Sanchez-Borges M, Cardona-Villa R et al. 2014. Multinational experience with hypersensitivity drug reactions in Latin America. Ann Allergy Asthma Immunol 113:282–9. https://doi.org/10.1016/j.anai.2014.06.019; PMid:25065979
Jennings RT, Baker ES. 2000. Gynecological and reproductive issues for women in space: a review. Obstet. Gynecol. Surv. 55;2:109–116. https://doi.org/10.1097/00006254-200002000-00025; PMid:10674254
Judlin P, Liao Q, Liu Z et al. 2010. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. Br J Obstet Gynaecol 117:1475–84. https://doi.org/10.1111/j.1471-0528.2010.02687.x; PMid:20716255
Kohl KS, Markowitz LE, Koumans EH. 2003. Developments in the screening for Chlamydia trachomatis: a review. Obstet Gynecol Clin North Am. 30(4):637-58. https://doi.org/10.1016/S0889-8545(03)00076-7
Lindbohm ML. 1999. Women's reproductive health: some recent developments in occupational epidemiology. Am. J. Ind. Med. 36;1:18–24. https://doi.org/10.1002/(SICI)1097-0274(199907)36:1<18::AID-AJIM3>3.0.CO;2-N
Lyon A. 2000. Chronic lung disease of prematurity. The role of intrauterine infection. Eur. J. Pediatr. 159:798–802. https://doi.org/10.1007/s004310000587; PMid:11079191
McGregor JA, Crombleholme WR, Newton E et al. 1994. Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis. Obstet Gynecol 83:998–1004. https://doi.org/10.1097/00006250-199406000-00020; PMid:8190448
Ness RB, Hillier SL, Kip KE et al. 2004. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 104:761–9. https://doi.org/10.1097/01.AOG.0000139512.37582.17; PMid:15458899
Ness RB, Kip KE, Hillier SL et al. 2005. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 162:585–90. https://doi.org/10.1093/aje/kwi243; PMid:16093289
Ness RB, Soper DE, Holley RL et al. 2002. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol 186:929–37. https://doi.org/10.1067/mob.2002.121625; PMid:12015517
Ness RB, Soper DE, Holley RL et al. 2002. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol 186:929–37. https://doi.org/10.1067/mob.2002.121625; PMid:12015517
Ochiel DO, Fahey JV, Ghosh M et al. 2008. Innate immunity in the female reproductive tract: role of sex hormones in regulating uterine epithelial cell protection against pathogens. Curr. Womens Hlth Rev. 4;2:102–117. https://doi.org/10.2174/157340408784246395; PMid:19644567 PMCid:PMC2717724
Prasertsawat PO, Jetsawangsri T. 1992. Split-dose metronidazole or single-dose tinidazole for the treatment of vaginal trichomoniasis. Sex Transm Dis 19:295–7. https://doi.org/10.1097/00007435-199209000-00011; PMid:1411848
Bonnin F et al. 1995. Prospective study of neonatal genital mycoplasma colonization and infection. Arch. Pediatr. 2:636–642. https://doi.org/10.1016/0929-693X(96)81217-6
Saji F. 1998. Immunological aspects of chorionamnionitis. Am. J. Reproduct. Immunol. 40:254.
Savaris RF, Teixeira LM, Torres TG et al. 2007. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. Obstet Gynecol 110:53–60. https://doi.org/10.1097/01.AOG.0000268801.90261.27; PMid:17601896
Schillinger JA, Kissinger P, Calvet H et al. 2003. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women - a randomized, controlled trial. Sex Transm Dis 30:49–56. https://doi.org/10.1097/00007435-200301000-00011; PMid:12514443
Smith KJ, Ness RB, Wiesenfeld HC et al. 2007. Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies. Sex Transm Dis 34:960–6. https://doi.org/10.1097/01.olq.0000225321.61049.13
Soroka AE et al. 2001. Genetic heterogeneity of Mycoplasma hominis clinical isolates detected during observation patients with recurrent urogenital inflammation. Bull. Exp. Biol. Med. 132;1:663–665. https://doi.org/10.1023/A:1012528311987; PMid:11687848
Sweet RL. 2011. Treatment of acute pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011:561909.
Tepper NK, Steenland MW, Gaffield ME et al. 2013. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Contraception 87:655–60. https://doi.org/10.1016/j.contraception.2012.08.011; PMid:23040135
Viberga I, Odlind V, Lazdane G et al. 2005. Microbiology profile in women with pelvic inflammatory disease in relation to IUD use. Infect Dis Obstet Gynecol 13:183–90. https://doi.org/10.1155/2005/376830; PMid:16338777 PMCid:PMC1784576
WHO. Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. Ed. M. Unemo et al. Printed by the Document Production Services, Geneva, Switzerland: 228. 2013.
Wiesenfeld HC, Hillier SL, Meyn L, et al. Mycoplasma genitalium – is it a pathogen in acute pelvic inflammatory disease (PID)? STI & AIDS World Congress 2013 (Joint Meeting of the 20th ISSTDR and 14th IUSTI Meeting). 2013, July 14-27. Vienna, Austria.
Wiesenfeld HC, Hillier SL, Meyn LA et al. 2012. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol 120:37–43. https://doi.org/10.1097/AOG.0b013e31825a6bc9; PMid:22678036
Wiesenfeld HC, Sweet RL, Ness RB et al. 2005. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 32:400–5. https://doi.org/10.1097/01.olq.0000154508.26532.6a; PMid:15976596
Workowski KA, Bolan GA. 2015. Sexually Transmitted Diseases Treatment Guidelines. MMWR Recomm Rep. 64(RR-03):1-137. Available at: https://www.ncbi.nlm.nih.gov/ pubmed/26042815. с.78.
##submission.downloads##
Опубліковано
Номер
Розділ
Ліцензія
Авторське право (c) 2020 Здоров’я жінки
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial 4.0 International License.
